PECCI, ALESSANDRO
 Distribuzione geografica
Continente #
NA - Nord America 7.636
AS - Asia 5.910
EU - Europa 4.579
SA - Sud America 767
Continente sconosciuto - Info sul continente non disponibili 487
AF - Africa 171
OC - Oceania 15
Totale 19.565
Nazione #
US - Stati Uniti d'America 7.398
CN - Cina 2.770
SG - Singapore 1.273
IE - Irlanda 985
IT - Italia 693
HK - Hong Kong 658
BR - Brasile 565
DE - Germania 519
FI - Finlandia 506
VN - Vietnam 506
RU - Federazione Russa 445
UA - Ucraina 402
FR - Francia 266
SE - Svezia 259
GB - Regno Unito 231
BD - Bangladesh 152
IN - India 135
CA - Canada 117
AR - Argentina 78
ZA - Sudafrica 69
TR - Turchia 63
NL - Olanda 62
IQ - Iraq 58
MX - Messico 54
JP - Giappone 52
EC - Ecuador 33
BE - Belgio 32
ES - Italia 28
ID - Indonesia 28
PK - Pakistan 27
PL - Polonia 24
MA - Marocco 23
MY - Malesia 23
CO - Colombia 22
CZ - Repubblica Ceca 18
SA - Arabia Saudita 18
VE - Venezuela 17
AT - Austria 16
RO - Romania 16
TN - Tunisia 16
CH - Svizzera 14
PH - Filippine 14
CL - Cile 13
CR - Costa Rica 13
UZ - Uzbekistan 13
AZ - Azerbaigian 12
DZ - Algeria 12
EG - Egitto 12
IR - Iran 12
JO - Giordania 11
KR - Corea 11
PA - Panama 11
PY - Paraguay 11
TH - Thailandia 11
BO - Bolivia 10
KE - Kenya 10
PE - Perù 10
JM - Giamaica 9
AU - Australia 8
BH - Bahrain 8
HN - Honduras 8
MU - Mauritius 8
RS - Serbia 8
UY - Uruguay 8
KG - Kirghizistan 7
SK - Slovacchia (Repubblica Slovacca) 7
AE - Emirati Arabi Uniti 6
NZ - Nuova Zelanda 6
DO - Repubblica Dominicana 5
ET - Etiopia 5
HU - Ungheria 5
OM - Oman 5
PS - Palestinian Territory 5
PT - Portogallo 5
BG - Bulgaria 4
DK - Danimarca 4
EU - Europa 4
GR - Grecia 4
KW - Kuwait 4
LB - Libano 4
LT - Lituania 4
MD - Moldavia 4
NI - Nicaragua 4
SV - El Salvador 4
TT - Trinidad e Tobago 4
AL - Albania 3
GE - Georgia 3
HR - Croazia 3
IL - Israele 3
KZ - Kazakistan 3
LK - Sri Lanka 3
SY - Repubblica araba siriana 3
BB - Barbados 2
CI - Costa d'Avorio 2
CV - Capo Verde 2
DM - Dominica 2
EE - Estonia 2
GH - Ghana 2
LC - Santa Lucia 2
LU - Lussemburgo 2
Totale 19.051
Città #
Dublin 981
San Jose 906
Chandler 834
Singapore 668
Hong Kong 643
Ashburn 633
Dallas 581
Jacksonville 571
Nanjing 555
Beijing 451
Boardman 279
Council Bluffs 252
Nanchang 217
Munich 208
Princeton 197
Wilmington 197
Ho Chi Minh City 187
Lawrence 180
Changsha 177
Lauterbourg 177
Los Angeles 170
Medford 164
Shenyang 159
Hebei 155
Helsinki 150
Milan 139
Jiaxing 127
New York 123
Hanoi 121
Ann Arbor 102
Buffalo 95
Pavia 94
Tianjin 92
Shanghai 83
Hangzhou 79
Moscow 75
Santa Clara 70
Turku 66
Redondo Beach 64
São Paulo 63
Johannesburg 58
Woodbridge 53
Orem 51
Houston 46
Tokyo 42
Montreal 37
Verona 37
Chennai 34
Brooklyn 32
Frankfurt am Main 31
Norwalk 31
Columbus 30
Guangzhou 29
London 29
Seattle 29
Toronto 29
Ankara 28
Rome 28
Denver 27
The Dalles 27
Atlanta 26
Brussels 26
Phoenix 26
Chicago 24
Da Nang 24
Mexico City 24
Fairfield 23
Nuremberg 23
Pune 23
Baghdad 21
Zhengzhou 21
Biên Hòa 19
San Francisco 19
Falkenstein 18
Naples 18
Amsterdam 17
Warsaw 17
Auburn Hills 16
Brasília 16
Falls Church 16
Haiphong 16
Ningbo 16
Boston 15
Jinan 15
Manchester 15
Stockholm 15
Rio de Janeiro 13
Secaucus 13
Belo Horizonte 12
Curitiba 12
Des Moines 12
Paris 12
Taizhou 12
Tashkent 12
Bari 11
Florence 11
Kuala Lumpur 11
Timisoara 11
Baku 10
Hải Dương 10
Totale 12.464
Nome #
Impaired respiratory function reduces haemoglobin oxygen affinity in COVID-19 349
Anemia in patients with Covid-19: pathogenesis and clinical significance 290
MYH9-Related Disorders. 274
Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy 178
A combination regimen of idarubicin and cytosine arabinoside for patients with high-risk myelodysplastic syndromes 168
Correction to: Anemia in patients with Covid-19: pathogenesis and clinical significance (Clinical and Experimental Medicine, (2021), 10.1007/s10238-020-00679-4) 164
A qualitative and quantitative cytochemical assay of dihydrofolate reductase in megakariocytes of patients with 5q-syndrome. 163
A case of phagocytic multiple myeloma 158
Correction to: Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy (Internal and Emergency Medicine, (2021), 16, 5, (1141-1152), 10.1007/s11739-020-02550-6) 153
Adhesive receptors, extracellular proteins and myosin IIA orchestrate proplatelet formation by human megakaryocytes. 151
NOVEL PERSPECTIVES IN GENOTYPE-PHENOTYPE CORRELATIONS IN MYH9-RELATED DISEASE: NO LONGER JUST A MATTER OF HEAD OR TAIL 151
Cochlear implantation is safe and effective in patients with MYH9-related disease. 144
5′UTR point substitutions and N-terminal truncating mutations of ANKRD26 in acute myeloid leukemia 144
A G to C transversion at the last nucleotide of exon 25 of the MYH9 gene results in a missense mutation rather than in a splicing defect. 143
Bleeding risk of surgery and its prevention in patients with inherited platelet disorders. The Surgery in Platelet disorders And Therapeutic Approach (SPATA) study 143
Clinical and pathogenetic characterization of ETV6-related thrombocytopenia (ETV6-RT), an inherited thrombocytopenia (IT) predisposing to childhood acute lymphoblastic leukemia (ALL) 142
Analysis of 339 pregnancies in 181 women with 13 different forms of inherited thrombocytopenia 141
ACTN1-related thrombocytopenia: identification of novel families for phenotypic characterization. 141
Cord blood-derived hematopoietic progenitor cells: in vitro response to hematopoietic growth factors and their recruitment into the S-phase of the cell cycle. 141
Impact of COVID-19 on liver function: results from an internal medicine unit in Northern Italy 141
Altered cytoskeleton organization in platelets from patients with MYH9-related disease. 140
Ex vivo immunosuppressive effects of mesenchymal stem cells on Crohn's disease mucosal T cells are largely dependent on indoleamine 2,3-dioxygenase activity and cell-cell contact 137
BERNARD SOULIER SYNDROME IN A PATIENT AFFECTED BY KLINEFELTER DISEASE: NOVEL A386G HOMOZYGOUS MUTATION OF GPIB alpha GENE WITH ANOMALOUS BEHAVIOUR 135
Germline mutations in ETV6 are associated with thrombocytopenia, red cell macrocytosis and predisposition to lymphoblastic leukemia 135
A case of metastatic malignant melanoma with bone marrow involvement. 131
A MONOALLELIC LOSS-FUNCTION MUTATION IN THE THROMBOPOIETIN (THPO) GENE IS RESPONSIBLE FOR A NEW FORM OF INHERITED THROMBOCYTOPENIA (IT) 131
3D silk bone marrow model: a promising tool to test efficacy of new biomimetic drugs on platelet production 131
Dihydrofolate reductase activity in the erythroblasts of patients with 5q-syndrome. 130
Endogenous fibronectin modulates collagen-dependent spreading and proplatelet formation by human megakaryocytes 129
Chaperone molecules concentrate together with the ubiquitin–proteasome system inside particulate cytoplasmic structures: possible role in metabolism of misfolded proteins 129
Spectrum of the mutations in Bernard-Soulier syndrome. 126
Ubiquitin/proteasome-rich particulate cytoplasmic structures (PaCSs) in the platelets and megakaryocytes of ANKRD26-related thrombo-cytopenia. 126
Cell cycle distribution of cord blood-derived haematopoietic progenitor cells and their recruitment into the S-phase of the cell cycle 126
Autosomal dominant thrombocytopenias with reduced expression of glycoprotein Ia 126
Bone marrow necrosis in acute lymphoblastic leukemia. 123
The myelodysplastic syndromes: predictive value of eight prognostic systems in 143 cases from a single institution. 122
A A386G biallelic GPIb alpha gene mutation with anomalous behavior: a new mechanism suggested for Bernard-Soulier syndrome pathogenesis. 122
Patients with Lemierre syndrome have a high risk of new thromboembolic complications, clinical sequelae and death: an analysis of 712 cases 121
Immunocytochemistry for the heavy chain of the non-muscle myosin IIA as a diagnostic tool for MYH9-related disorders. 121
Alteration of Liver Enzymes Is a Feature of the Myh9-Related Disease Syndrome. 121
A new form of inherited thrombocytopenia due to monoallelic loss of function mutation in the thrombopoietin gene 120
Clinical and laboratory features of 103 patients from 42 Italian families with inherited thrombocytopenia derived from the monoallelic Ala156Val mutation of GPIb{alpha} (Bolzano mutation). 120
Thrombopoietin is not uniquely responsible for thrombocytosis in inflammatory disorders 119
Clinical and genetic aspects Bernard-Soulier syndrome: searching for genotype/phenotype correlations. 119
A therapy-related myelodysplastic syndrome with unusual features in a patient treated for acute promyelocytic leukemia. 118
Platelet diameters in inherited thrombocytopenias: analysis of 376 patients with all known disorders. 117
THE D1424N AND R1933X MUTATIONS OF MYH9 CAUSE THROMBOCYTOPENIA THROUGH LOSS OF REGULATION OF PROPLATELET FORMATION BY TYPE I COLLAGEN. 117
Particulate cytoplasmic structures with high concentration of ubiquitin-proteasome accumulate in myeloid neoplasms 116
Both haploinsufficiency and dominant negative effects are responsible for abnormalities of patiens with MHY9-related disease. 116
A novel mutation in gp1bb reveals the role of the cytoplasmic domain of gpibβ in the pathophysiology of bernard‐soulier syndrome and gpib‐ix complex assembly 116
Inherited thrombocytopenias. The evolving spectrum. 115
Circulating CD34+, CD133+, and vascular endothelial growth factor receptor 2-positive endothelial progenitor cells in myelofibrosis with myeloid metaplasia. 113
X-linked thrombocytopenia with thalassemia: Clinical and biological features of a second family 113
β-1 tubulin R307H SNP alters microtubule dynamics and affects severity of a hereditary thrombocytopenia. 112
Clinical and pathogenic features of ETV6-related thrombocytopenia with predisposition to acute lymphoblastic leukemia 110
Eltrombopag in preparation for surgery in patients with severe MYH9-related thrombocytopenia 109
MYH9-related disease: five novel mutations expanding the spectrum of causative mutations and confirming genotype/phenotype correlations. 107
Common laboratory tests and their correlation with the clinical presentation and prognosis of Lemierre syndrome 106
Application of a diagnostic algorithm to 50 consecutive patients with inherited thrombocytopenias 106
MYH9 related disease: four novel mutations of the tail domain of myosin-9 correlating with a mild clinical phenotype. 106
Diagnostic and clinical relevance of the number of circulating CD34+ cells in myelofibrosis with myeloid metaplasia. 106
The Case. Proteinuria and low platelet count. 104
Lessons in platelet production from inherited thrombocytopenias. 104
Recent advances in the understanding and management of MYH9-related inherited thrombocytopenias. 104
R705H mutation of MYH9 is associated with MYH9-related disease and not only with non-syndromic deafness DFNA17. 103
Exome sequencing in 116 patients with inherited thrombocytopenia that remained of unknown origin after systematic phenotype-driven diagnostic workup 102
Transfection of the mutant MYH9 cDNA reproduces the most typical cellular phenotype of MYH9-related disease in different cell lines. 102
Thrombopoietin mutation in congenital amegakaryocytic thrombocytopenia treatable with romiplostim 102
BERNARD SOULIER SYNDROME IN A PATIENT AFFECTED BY KLINEFELTER DISEASE: NOVEL A386G HOMOZYGOUS MUTATION OF GPIB alpha GENE WITH ANOMALOUS BEHAVIOUR 102
Application of a diagnostic algorithm for inherited thrombocytopenias to 46 consecutive patients. 101
Eltrombopag for the treatment of inherited thrombocytopenias: A phase II clinical trial 101
Expression, activation, and subcellular localization of the Rap1, GTPase in human cord blood-derived megakaryocytes 100
Short-term eltrombopag for surgical preparation of a patient with inherited thrombocytopenia deriving from MYH9 mutation. 100
Mutations responsible for MYH9-related thrombocytopenia impair SDF-1-driven migration of megakaryoblastic cells. 99
The D1424N and R1933X mutations of MYH9 result in an altered proplatelet formation by human megakaryocytes 99
Efficacy and safety of factor VIII inhibitor by-passing activity (FEIBA) in high thrombotic risk patients with acquired haemophilia (AH) Efficacy and safety of factor VIII inhibitor by-passing activity (FEIBA) in high thrombotic risk patients with acquired haemophilia (AH) 99
Genetics, clinical and pathological features of glomerulonephritis associated with mutations of nonmuscle myosin IIA (Fechtner syndrome) 98
ETV6-RELATED THROMBOCYTOPENIA (ETV6-RT): CLINICAL AND PATHOGENETIC CHARACTERIZATION OF AN INHERITED THROMBOCYTOPENIA (IT) PREDISPOSING TO CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) 98
Dysregulation of oncogenic factors by GFI1B p32: investigation of a novel GFI1B germline mutation 98
NOVEL RUNX1 MUTATIONS IN FAMILIES WITH INHERITED THROMBOCYTOPENIA 97
Validation of the ISTH/SSC bleeding assessment tool for inherited platelet disorders: A communication from the Platelet Physiology SSC 97
Low-dose thalidomide ameliorates cytopenia and splenomegaly in myelofibrosis with myeloid metaplasia: a phase II clinical trial. 96
Expression, activation, and subcellular localization of the Rap1, GTPase in human cord blood-derived megakaryocytes. 96
The ISTH bleeding assessment tool as predictor of bleeding events in inherited platelet disorders: Communication from the ISTH SSC Subcommittee on Platelet Physiology 96
Expression, activation, and subcellular localization of the Rap1 GTPase in cord blood-derived human megakaryocytes. 95
Heavy chain myosin 9-related disease (MYH9-RD): neutrophil inclusions of myosin-9 as a pathognomonic sign of the disorder. 95
Dihydrofolate reductase activity in the erythroblasts of patients with 5q- syndrome. 95
Expression of dipeptidylaminopeptidase IV/CD26 in peripheral blood lymphocytes of hemophilic subjects. 95
ANKRD26-related thrombocytopenia and myeloid malignancies 95
ACTN1 mutations lead to a benign form of platelet macrocytosis not always associated with thrombocytopenia 95
The european hematology association roadmap for european hematology research: A consensus document 94
Platelet size distinguishes between inherited macrothrombocytopenias and immune thrombocytopenia. 93
Clinical and biological effects of treatment with amifostine in myelodysplastic syndromes 93
Cord blood in vitro expanded CD41+ cells: Identification novel components of megakaryocytopoiesis 93
Expression, activation and subcellular localization of the Rap1 GTPase in human cord blood-derived megakaryocytes 92
MYH9-related disease: a novel prognostic model to predict the clinical evolution of the disease based on genotype-phenotype correlations. 91
Expression of p53, bcl-2 and ras oncoproteins in acute leukemias and myelodysplastic syndromes 91
Endothelial colony-forming cells from patients with chronic myeloproliferative disorders lack the disease-specific molecular clonality marker. 91
Apoptosis in relation to CD34 antigen expression in normal and myelodysplastic bone marrow. 90
Severe to profound deafness may be associated with MYH9-related disease: Report of 4 patients 90
Totale 12.208
Categoria #
all - tutte 84.615
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 84.615


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022851 0 1 21 14 38 29 26 47 49 39 122 465
2022/20232.484 265 165 14 215 237 250 2 125 1.097 12 67 35
2023/20241.020 96 166 25 81 161 237 55 54 8 50 45 42
2024/20252.960 70 235 77 96 68 197 201 238 643 100 341 694
2025/20267.201 498 470 882 841 747 307 1.381 364 608 502 356 245
2026/2027510 176 334 0 0 0 0 0 0 0 0 0 0
Totale 19.565